DORI F. ZALEZNIK, M.D.
Osteopathic Medicine at Brookline Ave, Boston, MA
License number
Massachusetts 45229
Category
Osteopathic Medicine
Type
Infectious Disease
Address
Address
2
330 Brookline Ave, Boston, MA 02215
25 Sky View Cir, Newton, MA 02459
25 Sky View Cir, Newton, MA 02459
Phone
(617) 632-0760
(617) 632-0766 (Fax)
(617) 244-5380
(617) 969-1167 (Fax)
(617) 632-0766 (Fax)
(617) 244-5380
(617) 969-1167 (Fax)
Personal information
See more information about DORI F. ZALEZNIK at radaris.comName
Address
Phone
25 Sky View Cir, Newton Center, MA 02459
28 Heatherland Rd, Newton Highlands, MA 02461
66 Dalby St, Newton, MA 02458
Professional information
Dr. Dori F Zaleznik, Boston MA - MD (Doctor of Medicine)
Specialties:
Internal Medicine
Address:
330 Brookline Ave, Boston 02215
(617) 632-0760 (Phone), (617) 632-0766 (Fax)
(617) 632-0760 (Phone), (617) 632-0766 (Fax)
Certifications:
Internal Medicine, 1980
Awards:
Healthgrades Honor Roll
Languages:
English, Russian, Spanish
Hospitals:
330 Brookline Ave, Boston 02215
Beth Israel Deaconess Medical Center
330 Brookline Ave, Boston 02215
Beth Israel Deaconess Medical Center
330 Brookline Ave, Boston 02215
Education:
Medical School
Harvard Medical School
Beth Israel Hospital
Brigham and Women's Hospital
Harvard Medical School
Beth Israel Hospital
Brigham and Women's Hospital
Anti-Bacterial T-Cell Factor
US Patent:
5019513, May 28, 1991
Filed:
Jan 12, 1989
Appl. No.:
7/296849
Inventors:
Dennis L. Kasper - Newton Center MA
Dori F. Zaleznik - Newton Highlands MA
Robert W. Finberg - Roslindale MA
Dori F. Zaleznik - Newton Highlands MA
Robert W. Finberg - Roslindale MA
Assignee:
The Brigham and Women's Hospital, Inc. - Boston MA
International Classification:
C12N 518, C12P 2100
US Classification:
43524026
Abstract:
A method of protecting a mammal against a pathogenic bacterium by administering a soluble suppressor T-cell factor derived from a mammal that has been immunized with the bacterium or an antigenic surface fragment of the bacterium. Also disclosed are a hybrid cell fusion of an immunized suppressor T cell, methods of making such cells, and method of producing soluble suppressor T-cell factors.